CREATES Act of 2018

United States115th CongressS-974Senate
Updated: Jun 21, 2018

Summary

Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017 This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.

Bill texts

Available versions
View official text

2 versions available

All available records shown.

Timeline

  1. Introduced in Senate

  2. Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.

    Senate

  4. Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.

    Senate